Major Rating Factors:
Fair reserve development (3.6 on a scale of 0 to 10) as the level of reserves has at times been insufficient to cover claims. Deficiencies in the two year reserve development occurred in three of the previous five years and ranged between 16.0% and 19.7%. Fair profitability index (3.5) with operating losses during 2021, 2022 and 2023. Average return on equity over the last five years has been poor at -3.1%. Good long-term capitalization index (5.2) based on good current risk adjusted capital (severe loss scenarios), although results have slipped from the excellent range over the last two years.
Other Rating Factors:
Good overall results on stability tests (5.2) despite negative cash flow from operations for 2024. Stability strengths include good operational trends, good risk adjusted capital for prior years and good risk diversification. The largest net exposure for one risk is conservative at 1.6% of capital. Excellent liquidity (7.6) with ample operational cash flow and liquid investments.
Stability Factors:
F - Negative cash flow.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
DE, FL, GA, MA, MD, MI, MO, NC, NH, NJ, NV, OH, PA, RI, SC, TX
Principal Investments:
Investment grade bonds (89.7%), cash (2.6%), common stock (1.2%), non investment grade bonds (0.7%), other (5.8%)
Corporate Info
Group Affiliation
Ins Capital Group LLC
Investment Rating
Company Address
100 Berwyn Park
Berwyn, PA 19312
Berwyn, PA 19312
Phone Number
(610) 644-5262
NAIC Number
11863
Largest Affiliates
No affiliate information available.